Whole grain

Whole grain has been studied in 3 papers since 2011: 2 observational studies in people; 1 in the past year. The newest paper, Oct 20, 2026: “Diet-attributable vascular/metabolic disease burden comparisons and public health implications in Western Europe and North America”.

Intervention

3 papers study it7 findingsUpdated

1 new paper in 30 daysSee all 3 papers on whole grain

At a glance

The findings reach people, from one lab or study. 4 independent labs in 4 countries.

“After the intervention, the mean level of IL-22 in the WG group (9.9 ± 6.2 pg/mL) was significantly lower than that in the RG group (12.4 ± 6.3 pg/mL, P < 0.05).”
Comprehensive modulatory effects of whole grain consumption on immune-mediated inflammation in middle-aged and elderly community residents: A real-world randomized controlled trialRedox biology2024doi:10.1016/j.redox.2024.103337

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 4 independent labs in 4 countries
  • Funders: Beijing Friendship Hospital and 8 more
  • Humans2
  • In silico1

What did studies of whole grain find?

3

Studies of whole grain measured 3 outcomes: lipid and ceramide metabolism, body weight and IL-22.

Lipid and ceramide metabolism

downin humans1

1 study
  1. Whole grain decreases lipid and ceramide metabolism in humans (-0.4 mg/dL (95% CI, -0.7 to -0.1)).

    “Following a 12-week period of intervention, both the 50 g/d and 100 g/d whole grain groups demonstrated a substantial decline in triglycerides and total cholesterol.”

    Human trial100 g/d12-weekn = 115

    Effectiveness of whole grain to body weight and cardiometabolic risk in adults with obesity: a parallel randomised controlled trial

    Frontiers in nutrition

More on Lipid and ceramide metabolism

Body weight

downin humans1

1 study
  1. Whole grain decreases body weight in humans (-2.0 kg (95% CI, -3.1 to -0.8)).

    “Following adjustment for confounders, the mean weight change from baseline to 12 weeks between the 50 g/d whole grain group and the control group was −2.0 kg (95% CI, −3.1 to −0.8), and −1.7 kg (95% CI, −2.7 to −0.6) between the 100 g/d whole grain group and the control group.”

    Human trial50 g/d12-weekn = 115

    Effectiveness of whole grain to body weight and cardiometabolic risk in adults with obesity: a parallel randomised controlled trial

    Frontiers in nutrition

IL-22

downin humans1

1 study
  1. Whole grain decreases IL-22 in humans (9.9 ± 6.2 vs 12.4 ± 6.3 pg/mL).

    “After the intervention, the mean level of IL-22 in the WG group (9.9 ± 6.2 pg/mL) was significantly lower than that in the RG group (12.4 ± 6.3 pg/mL, P < 0.05).”

    Human trial6-weekn = 144

    Comprehensive modulatory effects of whole grain consumption on immune-mediated inflammation in middle-aged and elderly community residents: A real-world randomized controlled trial

    Redox biology

More on IL-22

What is whole grain linked with?

4

Studies link whole grain with 4 measures, among them short-chain fatty acids, cardiovascular disease mortality and mortality.

Short-chain fatty acids

upin humans1

1 study
  1. Whole grain is associated with short-chain fatty acids in humans (20.5 ± 6.3 vs 16.9 ± 5.6 %).

    “And then, after the 6-week intervention, the mean level of fecal butyric acid in the RG group (16.9 ± 5.6 %) was significantly lower than the WG group (20.5 ± 6.3, P < 0.05).”

    Human trial6-weekn = 144

    Comprehensive modulatory effects of whole grain consumption on immune-mediated inflammation in middle-aged and elderly community residents: A real-world randomized controlled trial

    Redox biology

More on Short-chain fatty acids

Cardiovascular disease mortality

downin humans1HR 0.85

1 study
  1. Whole grain is linked with a lower risk of cardiovascular disease mortality in humans (> 300 g/week vs never whole grain intake) (HR 0.85, 0.74-0.98).

    “the highest intake category of whole grain (> 300 g/week) was associated with lower risk of all-cause (HR 0.90, 95% CI 0.82-0.98) and CVD mortality (HR 0.85, 0.74-0.98).”

    Humans> 300 g/week vs never whole grain intake> 300 g/week

    Cereal intake and mortality in older Chinese: a 15-year follow-up of a prospective cohort study

    European journal of nutrition

More on Cardiovascular disease mortality

Mortality

downin humans1HR 0.9

1 study
  1. Whole grain is linked with a lower risk of mortality in humans (> 300 g/week vs never whole grain intake) (HR 0.90, 95% CI 0.82-0.98).

    “the highest intake category of whole grain (> 300 g/week) was associated with lower risk of all-cause (HR 0.90, 95% CI 0.82-0.98) and CVD mortality”

    Humans> 300 g/week vs never whole grain intake> 300 g/week

    Cereal intake and mortality in older Chinese: a 15-year follow-up of a prospective cohort study

    European journal of nutrition

Coronary artery disease

downin humans1

1 study
  1. Whole grain is associated with coronary artery disease in humans (significantly lower intake (p<0.0001)).

    “Subjects with coronary heart disease had significantly lower intake of foods containing high levels of magnesium like whole grain (p<0.0001), legumes (p<0.05) and nuts (p<0.05).”

    Humansn = 290

    Dietary magnesium intake and coronary heart disease risk: a study from Serbia

    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina

More on Coronary artery disease

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months